10.06.2015 • News

Chemours Spin-off from DuPont Finalized for July 1

DuPont’s board of directors has given final approval for the spin-off of the US group’s performance chemical business into a new standalone company known as The Chemours Company with effect from July 1, 2015.
In the spin-off, DuPont’s shareholders will receive one share of Chemours common stock for every five shares they hold in DuPont.
Trading of the shares is expected to begin on or about June 19 under the symbol “CC WI” on the New York Stock Exchange and continue through June 30.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.